JP2009504650A5 - - Google Patents

Download PDF

Info

Publication number
JP2009504650A5
JP2009504650A5 JP2008526082A JP2008526082A JP2009504650A5 JP 2009504650 A5 JP2009504650 A5 JP 2009504650A5 JP 2008526082 A JP2008526082 A JP 2008526082A JP 2008526082 A JP2008526082 A JP 2008526082A JP 2009504650 A5 JP2009504650 A5 JP 2009504650A5
Authority
JP
Japan
Prior art keywords
mepeg
formulation
glycol
peptide compound
polyethylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008526082A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009504650A (ja
Filing date
Publication date
Priority claimed from US11/200,416 external-priority patent/US7723295B2/en
Application filed filed Critical
Publication of JP2009504650A publication Critical patent/JP2009504650A/ja
Publication of JP2009504650A5 publication Critical patent/JP2009504650A5/ja
Pending legal-status Critical Current

Links

JP2008526082A 2005-08-09 2006-08-03 Tpo受容体と結合するペプチドの使用 Pending JP2009504650A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/200,416 US7723295B2 (en) 2003-08-28 2005-08-09 Peptides and compounds that bind to a receptor
PCT/US2006/030359 WO2007021572A2 (en) 2005-08-09 2006-08-03 Use of peptides that bind to tpo receptor

Publications (2)

Publication Number Publication Date
JP2009504650A JP2009504650A (ja) 2009-02-05
JP2009504650A5 true JP2009504650A5 (https=) 2009-06-04

Family

ID=37734435

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008526082A Pending JP2009504650A (ja) 2005-08-09 2006-08-03 Tpo受容体と結合するペプチドの使用

Country Status (34)

Country Link
US (1) US7723295B2 (https=)
EP (1) EP1957517B1 (https=)
JP (1) JP2009504650A (https=)
KR (1) KR20080048026A (https=)
CN (1) CN101287749A (https=)
AR (1) AR055114A1 (https=)
AU (1) AU2006280230B2 (https=)
BR (1) BRPI0614647A2 (https=)
CA (1) CA2618958A1 (https=)
CR (1) CR9798A (https=)
CY (1) CY1114032T1 (https=)
DK (1) DK1957517T3 (https=)
EA (1) EA200800535A1 (https=)
EC (1) ECSP088169A (https=)
ES (1) ES2419005T3 (https=)
GT (1) GT200600361A (https=)
HR (1) HRP20130518T1 (https=)
IL (1) IL189361A (https=)
JO (1) JO2859B1 (https=)
MY (1) MY152177A (https=)
NI (1) NI200800040A (https=)
NO (1) NO344405B1 (https=)
NZ (1) NZ565497A (https=)
PE (1) PE20070416A1 (https=)
PL (1) PL1957517T3 (https=)
PT (1) PT1957517E (https=)
RS (1) RS52802B (https=)
SI (1) SI1957517T1 (https=)
SV (1) SV2008002648A (https=)
TW (1) TWI400081B (https=)
UA (1) UA96418C2 (https=)
UY (1) UY29736A1 (https=)
WO (1) WO2007021572A2 (https=)
ZA (1) ZA200802184B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
KR20050093759A (ko) 2002-09-18 2005-09-23 오르토-맥네일 파마슈티칼, 인코퍼레이티드 혈소판 및 조혈 줄기세포의 생산을 증가시키는 방법
US20040149235A1 (en) * 2002-10-04 2004-08-05 Pogue Albert S. Apparatus and method for removal of waste from animal production facilities
US7615533B2 (en) * 2004-08-16 2009-11-10 Janssen Pharmaceutica N.V. TPO peptide compounds for treatment of anemia
US20090053242A1 (en) * 2006-01-25 2009-02-26 Amgen Inc. Thrombopoietic compounds
KR20110015448A (ko) * 2008-06-03 2011-02-15 얀센 파마슈티카 엔.브이. 암 치료와 관련된 혈액 질환을 예방하기 위한 tpo 모방 펩티드
EP2725053B1 (en) 2011-06-23 2016-02-10 Shimadzu Corporation Branched amphipathic block polymer and molecular aggregate and drug delivery system using same
CA3070442A1 (en) 2017-07-26 2019-01-31 Janssen Pharmaceutica Nv Methods of protecting vascular integrity induced by targeted radiation therapy
MX2021008928A (es) 2019-01-25 2021-11-04 Janssen Pharmaceutica Nv Métodos para mejorar la protección contra lesiones vasculares y de organos, la recuperación hematopoyética y la supervivencia en respuesta a la radiacion corporal total/exposicion química.
CN113905754B (zh) 2019-01-25 2025-03-11 詹森药业有限公司 减轻起疱剂和腐蚀性气体毒性作用的方法
CN113766926A (zh) 2019-01-25 2021-12-07 詹森药业有限公司 与放射和/或放射模拟物治疗结合的减轻肝损伤和促进肝肥大、再生和细胞植入的方法
US20240156973A1 (en) * 2021-02-24 2024-05-16 Purdue Research Foundation Osteotropic compositions and uses thereof
WO2023056444A1 (en) 2021-10-01 2023-04-06 Janssen Pharmaceutica N.V. Methods of increasing progenitor cell production
WO2024095178A1 (en) 2022-11-01 2024-05-10 Janssen Pharmaceutica Nv Thrombopoietin mimetic for use in the treatment of acute liver failure

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5326558A (en) * 1989-08-08 1994-07-05 Genetics Institute, Inc. Megakaryocytopoietic factor
IL96477A0 (en) 1989-12-01 1991-08-16 Amgen Inc Megakaryocyte production
DK167813B1 (da) * 1989-12-07 1993-12-20 Carlbiotech Ltd As Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
US5571508A (en) 1989-12-18 1996-11-05 Amrad Corporation Limited Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
IT1241395B (it) 1990-04-02 1994-01-10 Eniricerche Spa Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
US5141851A (en) * 1990-04-18 1992-08-25 Board Of Regents, The University Of Texas System Isolated farnesyl protein transferase enzyme
US5250732A (en) * 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
ES2181691T5 (es) 1992-06-11 2007-10-01 Alkermes Controlled Therapeutics, Inc. Sistema de distribucion de proteina eritropoyetina.
JP3401005B2 (ja) * 1992-12-11 2003-04-28 ユニバーシティ オブ フロリダ 有害生物の防除のための材料および方法
AU8124694A (en) 1993-10-29 1995-05-22 Affymax Technologies N.V. In vitro peptide and antibody display libraries
SG47030A1 (en) 1994-01-03 1998-03-20 Genentech Inc Thrombopoietin
SK100896A3 (en) 1994-02-14 1997-10-08 Zymogenetics Inc Hematopoietic protein and materials and methods for making it
EP0668352A1 (en) 1994-02-14 1995-08-23 Kirin Brewery Company, Ltd. Protein having TPO activity
WO1995021626A1 (en) 1994-02-14 1995-08-17 University Of Washington Methods for stimulating erythropoiesis using thrombopoietin
WO1995021919A2 (en) 1994-02-14 1995-08-17 Kirin Brewery Company, Limited Protein having tpo activity
CN1229385C (zh) 1994-03-31 2005-11-30 安姆根有限公司 刺激巨核细胞生长和分化的组合物及方法
US5571686A (en) 1994-04-14 1996-11-05 Massachusetts Institute Of Technology Method of using megapoietin for prolonging the survival & viability of platlets
AU4163196A (en) 1994-11-30 1996-06-19 Zymogenetics Inc. Low molecular weight thrombopoietin
AU705064B2 (en) 1995-04-26 1999-05-13 Kyowa Hakko Kogyo Co. Ltd. Novel polypeptides
TR199701526T1 (xx) * 1995-06-07 1998-03-21 Glaxo Group Limited Bir trombopoietin resept�r�ne ba�lanan peptitler ve bile�ikler.
US5869451A (en) 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6251864B1 (en) * 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6060052A (en) * 1995-10-30 2000-05-09 Systemix, Inc. Methods for use of Mpl ligands with primitive human hematopoietic stem cells
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
ATE350044T1 (de) 1999-09-24 2007-01-15 Smithkline Beecham Corp Thrombopoietinmimetika
AU2002307062A1 (en) 2001-04-02 2002-10-15 Purdue Pharma L.P. Thrombopoietin (tpo) synthebody for stimulation of platelet production
KR20050093759A (ko) 2002-09-18 2005-09-23 오르토-맥네일 파마슈티칼, 인코퍼레이티드 혈소판 및 조혈 줄기세포의 생산을 증가시키는 방법
US7576056B2 (en) 2003-08-28 2009-08-18 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor

Similar Documents

Publication Publication Date Title
JP2009504650A5 (https=)
EP1499358B1 (en) Ph-sensitive polymer
JP4490291B2 (ja) 薬物送達媒体としてのマルチアーム(multi−arm)ポリペプチド−ポリ(エチレングリコール)ブロックコポリマー
JP5277439B2 (ja) 核酸内包高分子ミセル複合体
EA023503B1 (ru) Галогенводородная солевая форма конъюгата многолучевого полимера и лекарственного средства, способ ее приготовления, композиции и способ лечения рака
US20130338352A1 (en) Derivative of hyaluronic acid modified with amino-carboxylic acid
US20100069500A1 (en) Amide dendrimer compositions
WO2013138731A1 (en) Polymeric conjugates of c1-inhibitors
WO2006105172A2 (en) Peg-polyacetal and peg-polyacetal-poe graft copolymers and pharmaceutical compositions
US20200283582A1 (en) Cationic Mucic Acid Polymer-Based Delivery Systems
US20150011645A1 (en) Amine dendrimers
JP2008542399A5 (https=)
US20250360187A1 (en) Hepcidin mimetics for treatment of sickle cell disease
US20150094379A1 (en) Dendrimer Compositions
HRP20170810T1 (hr) Peptidi i spojevi koji se vežu za receptore trombopoietina
CN101899091B (zh) 脂肪烷基五肽缀合物及其制备方法和在医学中的应用
US10730999B2 (en) Dendrimer-drug conjugates
NZ532719A (en) Thymosin alpha 1 peptide polymer conjugates for increasing half life of the peptide in serum
JP2025527514A (ja) 鉄ナノキレート剤の持続放出のための注射用感温性ヒドロゲル
ES3015278T3 (en) Mucoadhesive microgel compositions and methods for using the same
KR101788610B1 (ko) 의약용 단백질의 지속방출을 위한 약물전달체 및 이의 제조방법
WO2011065916A1 (en) Crosslinking branched molecule through thiol-disulfide exchange to form hydrogel
WO2019094868A1 (en) Biodegradable polymer and use thereof
CN107970204A (zh) 水凝胶组合物及包含其的药物递送系统
US11583587B2 (en) Polymer